Save

Effectiveness of two probiotics in preventing necrotising enterocolitis in a cohort of very-low-birth-weight premature new-borns

in Beneficial Microbes
Autor:innen:
J. Uberos Neonatal Intensive Care Unit, San Cecilio Clinical Hospital, Avda. Dr. Oloriz 16, 18012 Granada, Spain.
Medicine Faculty, University of Granada, Avda. de la Investigación 11, 18016 Granada, Spain.

Search for other papers by J. Uberos in
Current site
Google Scholar
PubMed
Close
,
A. Campos-Martinez Neonatal Intensive Care Unit, San Cecilio Clinical Hospital, Avda. Dr. Oloriz 16, 18012 Granada, Spain.

Search for other papers by A. Campos-Martinez in
Current site
Google Scholar
PubMed
Close
,
E. Fernandez-Marín Neonatal Intensive Care Unit, San Cecilio Clinical Hospital, Avda. Dr. Oloriz 16, 18012 Granada, Spain.

Search for other papers by E. Fernandez-Marín in
Current site
Google Scholar
PubMed
Close
,
I. Cubero Millan Neonatal Intensive Care Unit, San Cecilio Clinical Hospital, Avda. Dr. Oloriz 16, 18012 Granada, Spain.

Search for other papers by I. Cubero Millan in
Current site
Google Scholar
PubMed
Close
,
A. Ruiz Lopez Neonatal Intensive Care Unit, San Cecilio Clinical Hospital, Avda. Dr. Oloriz 16, 18012 Granada, Spain.

Search for other papers by A. Ruiz Lopez in
Current site
Google Scholar
PubMed
Close
, und
E. Blanca-Jover Neonatal Intensive Care Unit, San Cecilio Clinical Hospital, Avda. Dr. Oloriz 16, 18012 Granada, Spain.

Search for other papers by E. Blanca-Jover in
Current site
Google Scholar
PubMed
Close
Zitierung herunterladen Berechtigungen erhalten

Optionen für den Zugriff

Nutzen Sie bitte eine der untenstehenden Zugriffsmöglichkeiten, um den vollständigen Artikel zu lesen.

Institutszugang

Melden Sie sich mit Open Athens, Shibboleth oder Ihren institutionellen Anmeldedaten an.

Über Institut einloggen

Kauf

Sofortzugang erwerben (PDF-Download und unbegrenzter Online-Zugang):

36,93 €

Weitere Zugriffsmöglichkeiten

Auf DeepDyve mieten
Token einlösen

According to previous research, the incidence of necrotising enterocolitis (NEC) decreases after supplementation with probiotics. However, few studies have considered the equivalence or otherwise of different strains of probiotics in this respect. Accordingly, this prospective observational study was conducted in a cohort of 245 very-low-birth-weight (VLBW) new-borns to assess the prevalence of NEC after supplementation with the probiotic Inforan® (Berna Biotech, Madrid, Spain) 250 mg capsules containing 109 cfu of Lactobacillus acidophilus (ATCC 4356) and 109 cfu of Bifidobacterium bifidum (ATCC 15696); or with Bivos® (Ferring, Madrid, Spain) containing Lacticaseibacillus (formerly Lactobacillus) rhamnnosus (LGG) (ATCC 53103) (109 cfu); or with no probiotic supplementation. Statistical analysis was performed using multivariant regression for the duration of parenteral nutrition, length of neonatal intensive care unit stay, use of oxygen therapy and presence of chorioamnionitis. Of the VLBW new-borns in the study group, 65 received Infloran, 108 received Bivos and 72 received no probiotic. A significant association was observed between a reduced presence of NEC Stage ≥2 and probiotic supplementation. The odds risk (OR) obtained was 0.174 (95% confidence interval (CI): 0.032-0.936) for Infloran and 0.196 (95%CI: 0.053-0.732) for Bivos. Therefore, both probiotics are associated with a lower prevalence of NEC in VLBW new-borns, with no significant differences.

Kennzahlen

Insgesamt Letzte 365 Tage In den letzten 30 Tagen
Aufrufe von Kurzbeschreibungen 1031 303 34
Gesamttextansichten 51 13 1
PDF-Downloads 101 29 3